Scientists Are Trying to Train Lab-Grown Brains. The Brains Have Started to Solve Problems.

by admin | Mar 24, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Darren Orf – Popular Mechanics – Scientists trained a brain organoid to solve a well-known engineering task, and its success demonstrates the increasing complexity of lab-grown brains. While creating organs sounds like sci-fi fodder, scientists have...

New hope for treating a rare genetic disease before birth

by admin | Mar 23, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Stanford Medicine News – Stanford Medicine scientists are launching a clinical trial of prenatal transplants, using stem cells from the mother, to treat a rare genetic disease called Fanconi anemia before a baby is born. Stanford Medicine pediatric...

Giving stem cells room to breath

by admin | Mar 20, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Kyoto University – Nanogel integrated spheroids increase cell retention and repair injured swallowing muscles Kyoto, Japan — Swallowing is a fundamental human function that supports nutrition and communication. Damage to swallowing muscles can reduce...

Gene-based therapies poised for major upgrade thanks to Oregon State University research

by admin | Mar 19, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Steve Lundeberg – Oregon State University – by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells. Findings of the study spearheaded by Oregon State University College of Pharmacy graduate...

FDA must regulate stem cell therapies to mitigate risks to patients and the public

by admin | Mar 18, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By PNAS.org – In December 2025, the US Food and Drug Administration’s (FDA’s) Center for Biologics Evaluation and Review (CBER) approved a gene-based stem cell therapy for Wiskott–Aldrich syndrome, a rare and life-threatening genetic disease. This decision was...

$CAR T-cell Therapy Improves Survival in Relapsed or Refractory Lymphoma$

CAR T-cell Therapy Improves Survival in Relapsed or Refractory Lymphoma

by admin | Mar 17, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Melissa Rohman – NorthWwestern Medicine – CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone lymphoma, according to a recent clinical trial published in The Lancet. Marginal zone...